targeting aging cells that drive chronic age-related diseases. Our proprietary AI-driven ALEMBIC™ drug discovery platform is developing novel first-in-class small molecules to selectively target pathologic and senescent cells, which play a key role...
case. For context, the annual occupational exposure limit in the U.S. is 5,000 mRem—meaning an operator would need to perform over 31,000 cases before nearing that limit. With the typical interventionalist performing 300–500 cases annually, this...
dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market. For more information please, visit http://www.collplant.com.
operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, please visit www.merck.com
highlights both the scientific importance of ongoing advancements and the journal's role as a leading international platform for preclinical and translational research on anti-CD47 therapies. "Publication in the Journal of Hematology & Oncology...
medicine authentication and among the first globally to deploy the technology at commercial scale. Using ForgeStop’s platform, encrypted EM Microelectronic NFC labels are embedded into millions of drug packs, giving patients, pharmacists, and...
Alcami's private equity ownership includes GHO Capital, The Vistria Group, and Ampersand Capital Partners. For more information, please visit https://www.alcami.com.
About ADARx Pharmaceuticals ADARx Pharmaceuticals is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a broad range of therapeutic areas. We have developed...
advanced laboratory for molecular design and synthesis. At its core, the Chemifarm integrates Chemify’s Chemputation platform, an extensible programming language, advanced robotics, and the world’s largest curated library of validated reactions....
of its SurgiField System in Myanmar (Burma), where frontline medical teams used the portable surgical technology to perform life-saving procedures in active conflict zones. In a breakthrough demonstration, a Burmese doctor utilized the system to...
dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market. For more information please, visit http://www.collplant.com.
genetic testing for rare diseases, is piloting Illumina's emerging constellation mapped read technology, evaluating its performance on regions of the genome that traditional short-read technologies historically have not resolved. GeneDx's early...
tissue models that offer superior predictive power and ethical alternatives to traditional testing methods. For more information please visit, www.ctibiotech.com
proteomics to enable the earliest detection of disease, announced the launch of the NULISAqpcr™ BD-pTau217 Assay— a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217 (pTau217)—a pivotal biomarker in...
in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 50,000 employees worldwide, the company...
of Shanchol® have been supplied worldwide through UNICEF-led vaccination campaigns. After production was paused under its former ownership, GCBC Vaccines Pvt. Ltd. (formerly Shantha) has resumed manufacturing, with WHO conducting an on-site...
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology,...
as Chief Medical Officer. A physician-scientist with more than 15 years of experience in diagnostics and emerging platforms, Dr. Vucetic has directed medical and scientific strategies that move technologies from discovery to clinical settings,...
enabling long-term modulation of the classical and alternative pathways of the complement cascade. GA is an advanced form of dry AMD that leads to irreversible vision loss, with limited therapeutic options currently available. "FDA clearance of the...
Despite the transformative potential of Artificial Intelligence, a pervasive 'AI anxiety' is holding back a significant portion of the biopharma industry, a worry that is directly linked to the need for a clear return on investment, according to...
